[1] Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification[J]. J Thorac Oncol, 2015, 10(9): 1243-1260. DOI: 10.1097/JTO.0000000000000630 [2] Moon SW, Choi SY, Moon MH, et al. Effect of invasive mucinous adenocarcinoma on lung cancer-specific survival after surgical resection: A population-based study[J]. J Thorac Dis, 2018, 10(6): 3595-3608. DOI: 10.21037/jtd.2018.06.09 [3] Dacic S. Pros: the present classification of mucinous adenocarcinomas of the lung[J]. Transl Lung Cancer Res, 2017, 6(2): 230-233. DOI: 10.21037/tlcr.2017.04.11 [4] Lee HY, Cha MJ, Lee KS, et al. Prognosis in resected invasive mucinous adenocarcinomas of the lung: related factors and comparison with resected nonmucinous adenocarcinomas[J]. J Thorac Oncol, 2016, 11(7): 1064-1073. DOI: 10.1016/j.jtho.2016.03.011 [5] Watanabe H, Saito H, Yokose T, et al. Relation between thin-section computed tomography and clinical findings of mucinous adenocarcinoma[J]. Ann Thorac Surg, 2015, 99(3): 975-981. DOI: 10.1016/j.athoracsur.2014.10.065 [6] Lee MA, Kang J, Lee HY, et al. Spread Through Air Spaces (STAS) in invasive mucinous adenocarcinoma of the lung: Incidence, prognostic impact, and prediction based on clinicoradiologic factors[J]. Thorac Cancer, 2020, 11(11): 3145-3154. DOI: 10.1111/1759-7714.13632 [7] Cha YJ, Shim HS, et al. Biology of invasive mucinous adenocarcinoma of the lung[J]. Transl Lung Cancer Res, 2017, 6(5): 508-512. DOI: 10.21037/tlcr.2017.06.10 [8] Shimizu K, Okita R, Saisho S, et al. Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings[J]. OncoTargets Ther, 2016, 28(10): 153-163. DOI: 10.2147/OTT.S121059 [9] 王泽国, 郁万江, 娄和南, 等. 周围型肺腺癌表皮生长因子受体基因突变与CT上磨玻璃成分含量、病理的相关性[J]. 实用放射学杂志,2019,35(1):40-43,54. DOI: 10.3969/j.issn.1002-1671.2019.01.010 Wang ZG, Yu WJ, Lou HN, et al. Epidermal growth factor receptor mutation in peripheral lung adenocarcinoma: relationship with quantitative CT analysis of ground-glass opacity and histologic subtypes[J]. J Pract Radiol, 2019, 35(1): 40-43,54. DOI: 10.3969/j.issn.1002-1671.2019.01.010 [10] Cha YJ, Kim HR, Lee HJ, et al. Clinical course of stage IV invasive mucinous adenocarcinoma of the lung[J]. Lung Cancer, 2016, 102: 82-88. DOI: 10.1016/j.lungcan.2016.11.004 [11] Wang YD, Liu JC, Huang CC, et al. Development and validation of a nomogram for predicting survival of pulmonary invasive mucinous adenocarcinoma based on Surveillance, Epidemiology, and End Results (SEER) database[J]. BMC Cancer, 2021, 21(1): 148. DOI: 10.1186/s12885-021-07811-x [12] Guo MZ, Tomoshige K, Meister M, et al. Gene signature driving invasive mucinous adenocarcinoma of the lung[J]. EMBO Mol Med, 2017, 9(4): 462-481. DOI: 10.15252/emmm.201606711 [13] Miyamoto A, Kurosaki A, Fujii T, et al. HRCT features of surgically resected invasive mucinous adenocarcinoma associated with interstitial pneumonia[J]. Respirology, 2017, 22(4): 735-743. DOI: 10.1111/resp.12947 [14] Miyata N, Endo M, Nakajima T, et al. High-resolution computed tomography findings of early mucinous adenocarcinomas and their pathologic characteristics in 22 surgically resected cases[J]. Eur J Radiol, 2015, 84(5): 993-997. DOI: 10.1016/j.ejrad.2015.01.014 [15] 王康, 李铭, 周翔, 等. 孤立结节型肺黏液腺癌的CT表现与病理对照研究[J]. 临床放射学杂志,2020,39(9):1768-1772. DOI: 10.13437/j.cnki.jcr.2020.09.020 Wang K, Li M, Zhou X, et al. Solitary nodule pulmonary mucinous adenocarcinoma-comparison of CT findings and pathology[J]. J Clin Radiol, 2020, 39(9): 1768-1772. DOI: 10.13437/j.cnki.jcr.2020.09.020 [16] 聂凯, 于红, 刘士远, 等. 原发性肺浸润性黏液腺癌CT征象及病理特点[J]. 实用放射学杂志,2018,34(9):1335-1338,1380. DOI: 10.3969/j.issn.1002-1671.2018.09.007 Nie K, Yu H, Liu SY, et al. CT and pathological features of primary pulmonary invasive mucinous adenocarcinoma[J]. J Pract Radiol, 2018, 34(9): 1335-1338,1380. DOI: 10.3969/j.issn.1002-1671.2018.09.007 [17] 张磊, 谢超, 沈文荣. IA期肺腺癌的CT表现分型及其临床意义[J]. 临床放射学杂志,2019,38(9):1653-1657. DOI: 10.13437/j.cnki.jcr.2019.09.018 Zhang L, Xie C, Shen WR. Explore CT Classification and clinical significance for stage IA lung adenocarcinoma[J]. J Clin Radiol, 2019, 38(9): 1653-1657. DOI: 10.13437/j.cnki.jcr.2019.09.018
